Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Adagene
499
Adagene
Design
Technology
Health Care
Medical
Biotechnology
Therapeutics
Adagene is an antibody discovery and engineering company which seeks to establish technology-driven discovery partnerships.
Suggest edits
Type
B2c
Founded
2011
Raised
$147M
Follow us
Companies in the same industry
Nuritas
Scholar Rock
Prosensa
Rani Therapeutics
numares AG
myTomorrows
Biomoti
AZTherapies
Oncorus
Therachon AG
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$69,000,000
Venture capital (Series D) - 2020
General Atlantic
Sequoia Capital China
F-Prime Capital
+1
$50,000,000
Venture capital (Series C) - 2018
Sequoia China
New World TMT
AVIC Trust
+2
Team Size
2
Employees
I work here
Location
China
Headquarters
Explore China
Pulse 2.0
Adagene (ADAG) Stock: Why The Price Increased Today
DealStreetAsia
Chinese biotech firm Adagene plans $200m US IPO
$69,000,000
Venture capital (Series D)
DealStreetAsia
,
FinSMEs
China-based drug developer Adagene raises $69m led by General Atlantic
$50,000,000
Venture capital (Series C)
PE HUB
,
AVCJ
Adagene raises $50 mln
Messaging
Data leaks
FinSMEs
Adagene Raises $50M in Series C Funding
Funding
$28,000,000
Venture capital (Series B)
FinSMEs
Adagene Raises $28M in Series B Funding
Funding
